Treatment of Bipolar Disorder

| October 31, 2009 | 0 Comments

by Jeffrey Ventimiglia; Amir H. Kalali, MD; and Roger McIntyre, MD, FRCPC

Mr. Ventimiglia is an analyst in the Drug Safety and Medical Affairs Department, Quintiles, Inc., Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles, Inc., and Professor of Psychiatry, University of California, San Diego, California; and Dr. McIntyre is Associate Professor of Psychiatry and Pharmacology, Head, Mood Disorders Psychopharmacology Unit, University of Toronto, Ontario, Canada.

Psychiatry (Edgemont) 2009;6(10):12–15

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , , , ,

Category: Bipolar Disorder, Neurology, Past Articles, Psychiatry, Sleep Disorders, Trend Watch

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.